Skip to content

VersaCross Connect LAAC Access Solution VXAK0009 (REF NA)Recalls & reported problems

Baylis Médicale Cie Inc · 1 x VersaCross Connect Transseptal Dilator (including 1 x J-tip Mechanical Guidewire); 1 x VersaCross RF Wire (including 1 x Connector Cable (Single Use)); 1 x Dispersive Electrode · Class 2

All models of VersaCross Connect LAAC Access Solution (10)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00685447010548), received between Jan 27, 2026 and Jan 27, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Device-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device-Device Incompatibility1
  • Difficult to Advance1

Patient problems

  • Cardiac Perforation1
  • Cardiac Tamponade1
  • Pericardial Effusion1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2026Device-Device Incompatibility; Difficult to Advance

    IT WAS REPORTED THAT A CARDIAC PERFORATION, PERICARDIAL EFFUSION (PE) AND CARDIAC TAMPONADE OCCURRED. THE PROCEDURE WAS CANCELLED. DURING A LEFT ATRIAL APPENDAGE CLOSURE (LAAC) PROCEDURE, A VERSACROSS CONNECT LAAC WAS SELECTED FOR USE. THE PATIENT HAD PACEMAKER LEADS AND DUE TO THAT THE FELLOW PHYSICIAN WAS HAVING A HARD TIME NAVIGATING TO THE SUPERIOR VENA CAVA (SVC) WITH VERSACROSS RF WIRE. DURING SEVERAL ATTEMPTS TO CANNULATE THE SVC, AN EFFUSION IN RIGHT ATRIAL WAS NOTED ON TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE). THUS, A PERICARDIOCENTESIS WAS PERFORMED, AND THE DECISION WAS MADE TO TAKE THE PATIENT FOR SURGICAL REPAIR WHEN EFFUSION DID NOT RESOLVE AFTER. THE PLAN WAS TO HAVE THEM CLIP THE APPENDAGE IN SURGERY. THE PATIENT WAS STABLE UP UNTIL THEY WERE TRANSPORTED TO SURGERY AND THEY WERE HOSPITALIZED BEYOND STANDARD OF CARE. THE PATIENT IS EXPECTED TO FULLY RECOVERY. THE PERFORATION WAS LOCATED AT THE RIGHT ATRIAL (RA), PRIOR TO TRANSSEPTAL ATTEMPT. THE LEFT SIDE WAS NEVER ACCESSED. THE PATIENT WAS NOT UNDER WARFARIN AT THE TIME, AND THEY WERE UNDER ELIQUIS DURING THE PROCEDURE. THE DEVICE IS NOT EXPECTED TO BE RETURNED FOR ANALYSIS (DISPOSED).

    Patient problems: Cardiac Perforation; Cardiac Tamponade; Pericardial Effusion

    MAUDE report 24193451 ↗

Other Dilator, Vessel, For Percutaneous Catheterization devices

All Dilator, Vessel, For Percutaneous Catheterization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page